Mira Symillides

898 total citations
28 papers, 718 citations indexed

About

Mira Symillides is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Gastroenterology. According to data from OpenAlex, Mira Symillides has authored 28 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmaceutical Science, 11 papers in Pediatrics, Perinatology and Child Health and 9 papers in Gastroenterology. Recurrent topics in Mira Symillides's work include Drug Solubulity and Delivery Systems (19 papers), Pharmaceutical studies and practices (11 papers) and Statistical Methods in Clinical Trials (9 papers). Mira Symillides is often cited by papers focused on Drug Solubulity and Delivery Systems (19 papers), Pharmaceutical studies and practices (11 papers) and Statistical Methods in Clinical Trials (9 papers). Mira Symillides collaborates with scholars based in Greece, United Kingdom and Belgium. Mira Symillides's co-authors include Christos Reppas, Panos Macheras, Vangelis Karalis, Maria Vertzoni, Nikoletta Fotaki, Jennifer Dressman, Patrick Augustijns, Joachim Brouwers, Konstantinos Goumas and Bart Hens and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Mira Symillides

28 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mira Symillides Greece 19 455 149 123 116 115 28 718
Alfredo García‐Arieta Spain 16 488 1.1× 176 1.2× 184 1.5× 163 1.4× 165 1.4× 72 996
Nikunjkumar Patel United Kingdom 19 373 0.8× 73 0.5× 65 0.5× 105 0.9× 106 0.9× 36 795
Cordula Stillhart Switzerland 17 522 1.1× 167 1.1× 15 0.1× 160 1.4× 95 0.8× 32 883
Walter S. Woltosz United States 7 279 0.6× 84 0.6× 25 0.2× 56 0.5× 93 0.8× 12 616
Patrick Marroum United States 17 295 0.6× 123 0.8× 99 0.8× 115 1.0× 102 0.9× 36 777
Oliver Hatley United Kingdom 16 206 0.5× 145 1.0× 39 0.3× 58 0.5× 76 0.7× 27 952
Binfeng Xia United States 12 189 0.4× 79 0.5× 37 0.3× 50 0.4× 66 0.6× 19 470
Paulo Paixão Portugal 14 160 0.4× 61 0.4× 54 0.4× 57 0.5× 71 0.6× 34 608
Sivacharan Kollipara India 15 309 0.7× 63 0.4× 47 0.4× 126 1.1× 103 0.9× 46 643
Gunilla Hanisch Sweden 4 370 0.8× 49 0.3× 9 0.1× 147 1.3× 70 0.6× 4 507

Countries citing papers authored by Mira Symillides

Since Specialization
Citations

This map shows the geographic impact of Mira Symillides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mira Symillides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mira Symillides more than expected).

Fields of papers citing papers by Mira Symillides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mira Symillides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mira Symillides. The network helps show where Mira Symillides may publish in the future.

Co-authorship network of co-authors of Mira Symillides

This figure shows the co-authorship network connecting the top 25 collaborators of Mira Symillides. A scholar is included among the top collaborators of Mira Symillides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mira Symillides. Mira Symillides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vertzoni, Maria, et al.. (2020). Disposition of two highly permeable drugs in the upper gastrointestinal lumen of healthy adults after a standard high-calorie, high-fat meal. European Journal of Pharmaceutical Sciences. 149. 105351–105351. 18 indexed citations
2.
Statelova, Marina, Konstantinos Goumas, Nikoletta Fotaki, et al.. (2019). On the Design of Food Effect Studies in Adults for Extrapolating Oral Drug Absorption Data to Infants: an Exploratory Study Highlighting the Importance of Infant Food. The AAPS Journal. 22(1). 6–6. 12 indexed citations
3.
Vertzoni, Maria, et al.. (2016). Effectiveness of supersaturation promoting excipients on albendazole concentrations in upper gastrointestinal lumen of fasted healthy adults. European Journal of Pharmaceutical Sciences. 91. 11–19. 19 indexed citations
4.
Vertzoni, Maria, Mira Symillides, Bart Hens, et al.. (2016). In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGIT. International Journal of Pharmaceutics. 515(1-2). 352–358. 29 indexed citations
5.
Vertzoni, Maria, et al.. (2015). An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: Design, implementation, and evaluation. European Journal of Pharmaceutical Sciences. 82. 106–114. 56 indexed citations
6.
7.
Hens, Bart, Joachim Brouwers, Maura Corsetti, et al.. (2014). Gastrointestinal transfer: In vivo evaluation and implementation in in vitro and in silico predictive tools. European Journal of Pharmaceutical Sciences. 63. 233–242. 60 indexed citations
8.
Markopoulos, Christos, Georgios Imanidis, Maria Vertzoni, et al.. (2013). In Vitro and Ex Vivo Investigation of the Impact of Luminal Lipid Phases on Passive Permeability of Lipophilic Small Molecules Using PAMPA. Pharmaceutical Research. 30(12). 3145–3153. 11 indexed citations
9.
Symillides, Mira, Vangelis Karalis, & Panos Macheras. (2012). Exploring the Relationships Between Scaled Bioequivalence Limits and Within-Subject Variability. Journal of Pharmaceutical Sciences. 102(1). 297–301. 2 indexed citations
10.
Karalis, Vangelis, Mira Symillides, & Panos Macheras. (2011). Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA. Pharmaceutical Research. 29(4). 1066–1077. 53 indexed citations
11.
Karalis, Vangelis, Mira Symillides, & Panos Macheras. (2011). On the leveling-off properties of the new bioequivalence limits for highly variable drugs of the EMA guideline. European Journal of Pharmaceutical Sciences. 44(4). 497–505. 20 indexed citations
12.
Karalis, Vangelis, Mira Symillides, & Panos Macheras. (2010). Novel methods to assess bioequivalence. Expert Opinion on Drug Metabolism & Toxicology. 7(1). 79–88. 5 indexed citations
13.
Karalis, Vangelis, Mira Symillides, & Panos Macheras. (2009). Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: Focus on human exposure to drugs. European Journal of Pharmaceutical Sciences. 38(1). 55–63. 7 indexed citations
14.
Karalis, Vangelis, et al.. (2006). Novel Scaled Bioequivalence Limits with Leveling-off Properties. Pharmaceutical Research. 23(11). 2657–2664. 24 indexed citations
15.
Karalis, Vangelis, Panos Macheras, & Mira Symillides. (2005). Geometric mean ratio-dependent scaled bioequivalence limits with leveling-off properties. European Journal of Pharmaceutical Sciences. 26(1). 54–61. 29 indexed citations
16.
Fotaki, Nikoletta, Mira Symillides, & Christos Reppas. (2005). Canine versus in vitro data for predicting input profiles of l-sulpiride after oral administration. European Journal of Pharmaceutical Sciences. 26(3-4). 324–333. 40 indexed citations
17.
Vertzoni, Maria, Mira Symillides, Athanassios Iliadis, Eleftheria Nicolaides, & Christos Reppas. (2003). Comparison of simulated cumulative drug versus time data sets with indices. European Journal of Pharmaceutics and Biopharmaceutics. 56(3). 421–428. 20 indexed citations
18.
Reppas, Christos, Georgios Eleftheriou, Panos Macheras, et al.. (1998). The effect of HPMC—a cholesterol-lowering agent—on oral drug absorption in dogs. Biopharmaceutics & Drug Disposition. 19(8). 523–530. 6 indexed citations
19.
Reppas, Christos, Georgios Eleftheriou, Panos Macheras, Mira Symillides, & Jennifer Dressman. (1998). Effect of elevated viscosity in the upper gastrointestinal tract on drug absorption in dogs. European Journal of Pharmaceutical Sciences. 6(2). 131–139. 40 indexed citations
20.
Macheras, Panos & Mira Symillides. (1989). Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. Biopharmaceutics & Drug Disposition. 10(1). 43–53. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfredo García‐Arieta Breakdown of academic impact, for papers by Nikunjkumar Patel Breakdown of academic impact, for papers by Cordula Stillhart Breakdown of academic impact, for papers by Walter S. Woltosz Breakdown of academic impact, for papers by Patrick Marroum Breakdown of academic impact, for papers by Oliver Hatley Breakdown of academic impact, for papers by Binfeng Xia Breakdown of academic impact, for papers by Paulo Paixão Breakdown of academic impact, for papers by Sivacharan Kollipara Breakdown of academic impact, for papers by Gunilla Hanisch
Rankless by CCL
2026